A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in Advanced Squamous Cell Cancers
Hummingbird Bioscience
Hummingbird Bioscience
Maia Biotechnology
AVEO Pharmaceuticals, Inc.
KaliVir Immunotherapeutics
Alpha Tau Medical LTD.
Eli Lilly and Company
AstraZeneca
Neonc Technologies, Inc.
VLP Therapeutics
Maia Biotechnology
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
ImmVira Pharma Co. Ltd
Bicara Therapeutics
Alpha Tau Medical LTD.
Alpha Tau Medical LTD.
EpicentRx, Inc.